|
Characterization of Yeast Protein Deg1 as Pseudouridine Synthase
(Pus3) Catalyzing the Formation of 38 and
39 in tRNA Anticodon Loop*
François
Lecointe ,
George
Simos§,
Anke
Sauer§,
Eduard C.
Hurt§,
Yuri
Motorin ¶, and
Henri
Grosjean
From the Laboratoire d'Enzymologie et Biochimie
Structurales, CNRS, Gif-sur-Yvette, France and the
§ Universität Heidelberg, Institut für Biochemie
I, Im Neuenheimer Feld 328, D-69120 Heidelberg, Germany
 |
ABSTRACT |
The enzymatic activity of yeast gene product Deg1
was identified using both disrupted yeast strain and cloned recombinant protein expressed in yeast and in Escherichia coli. The
results show that the DEG1-disrupted yeast strain lacks
synthase activity for the formation of pseudouridines 38
and 39 in tRNA whereas the other activities, specific
for formation at positions 13, 27, 28, 32, 34, 35, 36, and 55 in
tRNA, remain unaffected. Also, the His6-tagged recombinant
yeast Deg1p expressed in E. coli as well as a protein
fusion with protein A in yeast display the enzymatic activity only
toward 38 and 39 formation in different
tRNA substrates. Therefore, Deg1p is the third tRNA:pseudouridine
synthase (Pus3p) characterized so far in yeast. Disruption of the
DEG1 gene is not lethal but reduces considerably the yeast
growth rate, especially at an elevated temperature (37 °C). Deg1p
localizes both in the nucleus and in the cytoplasm, as shown by
immunofluorescence microscopy. Identification of the pseudouridine
residues present (or absent) in selected naturally occurring
cytoplasmic and mitochondrial tRNAs from DEG1-disrupted
strain points out a common origin of 38- and
39-synthesizing activity in both of these two cellular compartments. The sensitivity of Pus3p (Deg1p) activity to overall three-dimensional tRNA architecture and to a few individual mutations in tRNA was also studied. The results indicate the existence of subtle
differences in the tRNA recognition by yeast Pus3p and by its
homologous tRNA:pseudouridine synthase truA from E. coli (initially called hisT or PSU-I gene
product).
 |
INTRODUCTION |
The modified nucleoside pseudouridine
(5-( -D-ribofuranosyl)uracil, abbreviated as
),1 is found very
frequently in all kinds of RNA from eubacteria, archaea, and eukaryotes
(1). It is present in all transfer RNAs (2), large and small subunits
of ribosomal RNA (3, 4), most small nuclear RNAs (5, 6), and selected
small nucleolar RNAs (7).
The numerous residues in RNA are produced by a family of enzymes
(pseudouridine synthases, RNA: synthases). These enzymes act on
specific uridine residues of the RNA molecules, but still very little
is known about the number of these enzymes in a given cell as well as
their mechanism and their RNA recognition mode.
In yeast tRNA, formation of pseudouridines at positions 13, 32, and 55 is catalyzed by three distinct enzymes (8), whereas in the same yeast
cell one single enzyme (Pus1p) is responsible for formation at
positions 27, 34, and 36 (9). Several distinct pseudouridine synthase
activities acting on eukaryotic small nuclear RNAs were also detected
in crude cell extracts (5); however, none of these enzymes has been
identified so far. From recent works on rRNA maturation, it appears
that most (if not all) of the in eukaryotic rRNA is probably
synthesized by a single (or at least very few) rRNA: synthase(s); in
this latter case the enzyme(s) is(are) guided to the different target
uridines within the rRNA by a huge family of diverse small nucleolar
ribonucleoproteins present in the nucleolus (10, 11; for review, see
Ref. 12).
The first RNA:pseudouridine synthase that was purified and fully
characterized came from Salmonella typhimurium (13) and later from Escherichia coli (14). It corresponds to a
tRNA: synthase (PSU-I, previously called hisT gene
product, recently renamed to truA). It catalyzes the
formation of 38, 39, and/or 40 in several cellular tRNAs. Only the gene for the
E. coli enzyme (PSU-I) was cloned and sequenced (15). The
E. coli PSU-Ip is a monomer with a molecular mass of 31 kDa
(270 amino acids), whereas PSU-Ip from S. typhimurium has a
subunit size of about 50 kDa and dimerizes in the presence of tRNA
substrate (13). A higher eukaryotic homolog of PSU-I from calf thymus
was highly enriched after five chromatographic steps (16); however, a
homogeneous preparation was not obtained. All of these enzymes have
similar properties: they do not require any cofactor, they catalyze the formation at contiguous sites (region specificity), and they demonstrate similar kinetic properties (13, 14, 16).
Recently three other E. coli RNA: synthases were
identified and their corresponding genes cloned: truB, which
is site-specific for at position 55 in tRNA (17); rluA,
specific for at position 32 in tRNA and at position 746 in 23 S
rRNA (dual specificity; Ref. 18); and rsuA, specific for U
at position 516 in 16 S rRNA associated with ribosomal proteins within
a ribosomal ribonucleoprotein complex (19).
The genes for two other tRNA:pseudouridine synthases (Pus1p and Pus2p)
from yeast were also identified, one of them (PUS1) was
cloned and overexpressed in E. coli (9). The recombinant yeast Pus1p was shown to be specific for at position 27 in several yeast tRNAs and for at positions 34 and 36 in the intron-containing pre-tRNAIle (9; for review, see Ref. 20). This enzyme has a
molecular mass of 62 kDa and was shown to be located essentially in the
yeast nucleus (9). The target RNA and position(s) of uridine to be modified by Pus2p (a 42-kDa protein) have not been determined yet.
Another yeast protein has been reported to be homologous to E. coli and S. typhimurium pseudouridine synthases PSU-I
(hisT gene product, truAp) (21). This protein (called Deg1
because disruption of the gene causes depressed growth; SacchDB
accession number YFL001W, SwissProt P31115) also displays a significant homology to the yeast Pus1p (9). Based on this sequence homology with
PSU-I, it was suggested (21) that Deg1 protein may possess the
corresponding activity of hisT gene product, but this
plausible hypothesis was never tested experimentally. Here we present
experimental evidence that yeast protein Deg1 is indeed a new distinct
yeast tRNA: synthase (Pus3p) with a slightly different specificity toward tRNA compared with E. coli enzyme truA since it
catalyzes the formation of only 38 and 39
(not 40). The structural substrate requirements and the
intracellular localization of Pus3p are also analyzed.
 |
EXPERIMENTAL PROCEDURES |
Chemicals, Enzymes, and
Materials--
-32P-Radiolabeled nucleotide
triphosphates (400 Ci/mmol) were from Amersham (U. K.). Tris,
dithioerythritol, dithiothreitol, nucleoside triphosphates,
Penicillium citricum nuclease P1, Aspergillus oryzae RNase T2, and phenylmethylsulfonyl fluoride were from
Sigma. Diisopropyl fluorophosphate and CMCT were from Aldrich.
Bacteriophage T7 RNA polymerase, restriction enzymes, and
isopropyl-1-thio- -D-galactopyranoside were from from MBI
Fermentas (Vilnius, Lithuania). RNasin and avian myeloblastosis virus
reverse transcriptase were from Promega. Synthetic
oligodeoxynucleotides used as primers for reverse transcription were purchased from MWG-Biotech (Germany) and used without further purification. Thin layer cellulose plates were from Schleicher & Schuell (Germany), and all other chemicals were from Merck Biochemicals (Germany).
Plasmids and Transcription of tRNA Genes--
The plasmids
carrying the synthetic genes of tRNAs used in this work were described
previously tRNAAsp (GUC) (22), pre-tRNAIle
(UAU) and its mutant (anticodon UUA) (23), pre-tRNATyr
(mutant UUA) (24), and E. coli tRNASer (GGA)
(25). Plasmids with cloned genes of yeast tRNAPhe (GAA) and
its mutants PheY54 (p67YF1, mutation C56G) and PheY55 (p67YF2,
mutations G19C and C56G) have been described (26). Plasmids carrying
yeast tRNAHis (GUG), yeast tRNASer (IGA), and
mutant yeast tRNAVal (harboring anticodon CAU instead of
UAC) were gifts, respectively, of Dr. J. Rudinger (IBMC, Strasbourg),
Dr. H. Himeno (Tokyo University, Japan), and Dr. F. Fasiolo (IBMC). The
synthetic gene for yeast tRNAAla (anticodon IGC) was
constructed by ligation of sets of complementary oligonucleotides as
described (22).
The DNA template for T7 transcription of E. coli
tRNALeu (CAG) and yeast intronless tRNATrp
(bearing a mutated anticodon CUA) were prepared by PCR amplification of
the corresponding sequence present in E. coli genomic DNA
and in plasmid (pT7T3am2 IVS, provided by Dr. J. B. Bell, University of Alberta, Canada) using two complementary oligonucleotides to each
gene sequence, one bearing a T7 promoter sequence and the other one
half of an MvaI restriction site. The minisubstrate composed
of the anticodon stem-loop of tRNAPhe (with and without
intron) was prepared by T7 transcription using synthetic
double-stranded DNA template as described (27).
In vitro T7 RNA-polymerase transcription using
-32P-radiolabeled nucleotide triphosphates and
purification of the resulting T7 runoff tRNA transcripts by urea gels
were performed as described (27, 28).
Yeast Strains, Media, and Microbiological Techniques--
The
wild type yeast strain used in this study was RS453 ( /a,
ade2/ade2, leu2/leu2, ura3/ura3, his3/his3, trp1/trp1), and all
mutant strains containing disrupted genes were derived from this one.
Yeast cells were grown on minimal SDC and rich YPD medium (37), and
sporulation of diploid cells on YPA plates and tetrad analysis were
performed according to Ref. 29. Minimal SDC medium/plates were
supplemented by all amino acids and nutrients except the ones used for
the selection or, if indicated, contained 5-fluoroorotic acid (CSM
medium, BIO 101, La Jolla). Genetic manipulations were performed as
described (30).
Cloning and Expression of Yeast Deg1p in E. coli--
Preparation of the construct for expression of Deg1 in yeast
was done as follows. The DEG1 gene was amplified by PCR from total yeast genomic DNA using two primers that created an
XbaI restriction site in the 5 -untranslated region of the
gene 151 nucleotides upstream of the start codon
(ttttttctagAATCAATGGGCTCAGCTC, complementary sequence in capital
letters) and an SalI restriction site
(tttttgtcgacAAGAAATATAGTCTTCAAGG) in the 3 -untranslated region of the
gene 50 nucleotides downstream of the stop codon. This allowed cloning
of the gene into a pRS315 vector previously cut with
XbaI/SalI. This construct could complement the
slow growing phenotype when transformed in the
deg1 haploid cells.
The construct for expression of His6-tagged recombinant
Deg1 in E. coli was prepared by the following procedure. The
DEG1 ORF was amplified by PCR from total yeast genomic DNA
using two primers that created an XhoI restriction site at
the ATG start codon (aaaaactcgagcAGTAATTTCATTAGAAGGCTAG) and an
MluI restriction site (aaaaaacgcgtAAGAAATATAGTCTTCAAGG) in
the 3 -untranslated region of the gene. This manipulation allowed
cloning of the ORF into a modified pET (pET-His6/pET8c)
vector previously cut with XhoI/MluI and created
an in-frame fusion protein of 6 histidine residues joined by a spacer
Ser-Ser dipeptide to the amino acid immediately after the start
methionine. The vector containing the fusion gene was transformed into
E. coli BL21(DE3) cells.
Gene Disruption of DEG1--
Disruption of the DEG1
gene was done by the one-step gene replacement method (31). In this
study, the DEG1 gene was disrupted by inserting a
BamHI fragment 0.9 kilobases long and containing the
HIS3 gene into the BamHI site of the
DEG1-ORF cloned in the pET8c vector. The disrupted gene was
excised and the linear fragments used to transform the diploid strain
RS453. HIS+ transformants with the correct
integration of the interrupted gene at the DEG1 locus were
verified by PCR analysis (data not shown). Correct integrants were
sporulated, and tetrads were dissected. A 4:0 segregation for viability
and a 2:2 segregation for the HIS marker were found for the
DEG1 gene disruption showing that this gene is not essential
for cell growth. However, all spores carrying a disrupted
DEG1 gene grew slower giving rise to small colonies as
reported previously (21).
Construction of Doubly Disrupted Mutants--
To construct a
haploid yeast strain in which the disrupted PUS1 and
DEG1 genes are combined, a PUS1
mutant harboring pURA3-PUS1 was mated to the mutant
DEG1 . The resulting heterozygous diploids were
sporulated, and tetrad analysis was performed. For complete tetrads in
which the HIS+/his
genotype segregates 2:2, one can predict that the two HIS+
progeny are
deg1::HIS3/pus1::HIS3.
A complete tetrad showing this segregation pattern was analyzed in
greater detail for the segregation of the HIS3 and
URA3 markers by plating cells on SDC-his and SDC-ura plates,
respectively. The HIS+ progeny
deg1::HIS3/pus1:HIS3
also contained the plasmid pURA3-PUS1; we could shuffle out this
plasmid and test whether the double mutant
pus1 /deg1 gives
synthetic lethality by plating this strain on 5-fluoroorotic acid
containing plates at 30 °C. The
los1 /deg1 strain was constructed
in a similar way.
Construction of the Deg1p Fusion Protein Carrying Protein A or
Green Fluorescent Protein (GFP) as a Tag--
Epitope tagging of Deg1p
was done by fusing two IgG binding units from Staphyloccus
aureus protein A to the N-terminal end of Deg1p. For this gene
fusion, a new PstI restriction site was generated at the ATG
codon of DEG1 by PCR-mediated mutagenesis, and the ORF was
subcloned into the plasmid pRS315 in-frame with the two IgG binding
units under the control of the NOP1 promoter (PNop1-ProtA cassette; see Ref. 32), creating the plasmid
pNOP-ProtA-Deg1. Affinity purification of the ProtA fusion protein was
done as described previously (32). Tagging with GFP was done in a
similar way, but the IgG binding units were replaced by the ORF for GFP (PNop1-GFP
cassette),2 creating the
plasmid pNOP-GFP-Deg1. The GFP used is a S65T/V163A variant exhibiting
enhanced fluorescence properties (33, 34).
Cellular Localization of DEG1 Gene Product--
Intracellular
localization of the ProtA-Deg1p fusion protein was performed by
indirect immunofluorescent microscopy as described in Ref. 9 using as
first antibody rabbit anti-protein A (Sigma) and as second antibody
CyTM3-conjugated AffiniPure donkey anti-rabbit IgG
(Dianova). GFP-Deg1p was observed in living cells by direct fluorescent
microscopy.
Pseudouridine Formation Assay in Vitro--
Preparation of S100
extract from yeast as well as from E. coli was made as
described elsewhere (25, 28). The activity of yeast extracts and
purified yeast enzyme fractions was tested at 30 °C; 37 °C was
used for testing E. coli extracts. The incubation mixture
contained 100 mM Tris-HCl, pH 8.0, 100 mM
ammonium acetate, 5 mM MgCl2, 2 mM
dithiothreitol, 0.1 mM EDTA, and 1-2 fmol of 32P-radiolabeled T7 runoff transcripts as substrate. After
incubation, the pseudouridine content in the radiolabeled transcripts
was analyzed as described previously (27, 28). In brief, the RNA was
first extracted with phenol-chloroform, precipitated in ethanol, and
then hydrolyzed completely to 3 -nucleotide monophosphates by RNase T2.
Each hydrolysate was chromatographed on two-dimensional thin layer
chromatography plates, and the radioactivity in the MP and UMP spots
was evaluated after exposing the thin layer chromatography plates with
a PhosphorImager screen. Taking into account the relative number of
MP and UMP in the tRNA molecule, the relative amount of over
tRNA molecule (expressed in mol/mol of tRNA) can be evaluated. The
accuracy of this method was found to be about ± 0.05 mol of
/mol of tRNA.
Identification and Localization of Naturally Occurring Residues in tRNAs--
Localization of pseudouridine residues in tRNA
was performed as described (35, 36) with the following modifications.
10 µg of total tRNA extracted from wild type or mutant yeast strain was treated by 0.17 M CMCT in Bicine-urea buffer, pH 7.5, for 15 min at 42 °C. Reverse transcription was done at 42 °C for
45 min using about 1 µg of CMCT-modified cytoplasmic tRNA or 3 µg of CMCT-modified mitochondrial tRNA and 1-2 pmol of
5 -32P-labeled synthetic oligodeoxynucleotide primer.
Reverse transcription products were separated on 15% denaturing
polyacrylamide gel. The oligodeoxynucleotide primers were chosen to be
complementary to the 18 nucleotides at the 3 -end of cytoplasmic
tRNAGly and mitochondrial tRNAArg,
respectively, because both of these tRNAs have a low content of
modified nucleotides downstream from the pseudouridylation sites.
Miscellaneous--
Isolation of total yeast DNA was done
essentially as described in Ref. 37. DNA and plasmid manipulations
(restriction analysis, end filling reactions, ligations, PCR
amplifications, DNA fragment recovery, and small scale and large scale
plasmid preparations) were done essentially according to standard
procedures (38). The nucleotide sequence of tRNA inserts in the various
plasmids used was verified systematically by the dideoxy sequencing
technique. Evaluation of the protein concentration was done according
to Bradford (39), and Western blotting was performed as described in
Ref. 9.
Screening of the nonredundant GenBank data base was performed using
BLAST algorithm, version 1.4.9; amino acid substitution matrix BLOSUM62
was used in all data base searches. Multiple sequence alignment was
constructed using Macintosh version of MACAW software, version
2.0.5.
 |
RESULTS |
Yeast Protein Deg1 Displays Significant Sequence Homology with E. coli truA and Yeast Pus1--
The accessibility of whole genome
sequencing data for several prokaryotic and eukaryotic organisms allows
the systematic screening for the corresponding enzymes based on
sequence homology. BLAST search, using the
hisT(truA) gene of E. coli (coding for
tRNA: 38-40 synthase; see Ref. 15) as a query sequence,
allows detection of several homologous proteins in the GenBank. Partial
sequence alignment of hisT(truA)-like proteins of
different origin is presented on Fig. 1.
These are mostly putative pseudouridine synthases I (PSU-I) from
several bacteria and lower eukaryotes. Higher eukaryotes are presented
by the partial nucleotide sequence of human (zn81c07.s1) Deg1-like
protein. All of these putative proteins display significant sequence
homology with E. coli truA (BLAST p value is less
than 0.001). All proteins share common signature blocks of amino acid, which suggests the same or similar function in the cellular metabolism. Here it is noteworthy to remember that the yeast PUS1 gene
also shares high homology with the truA(hisT)
gene, but the corresponding RNA: synthase has a different
specificity and properties (9). Also, as already noted by Koonin (40),
this group of hisT(truA)-like enzymes is rather
distant from the pseudouridine synthases identified so far, specific,
respectively, for 55 (E. coli truB-like), for 32 in tRNA and 746 in 23 S rRNA
(E. coli rluA-like), and for 516 in E. coli 18 S rRNA. From the above sequence homology one can expect
that protein Deg1 has enzymatic activity similar to that of E. coli truA.

View larger version (99K):
[in this window]
[in a new window]
|
Fig. 1.
Conserved sequence motifs in a family of
truA-like proteins. Putative pseudouridine synthases I
( 38/39/40) from Haemophilus influenzae
(U32837), Mycoplasma genitalium (U39695), B. burgdorferi (Y09141), Bacillus subtilis (D64126),
Synechocystis sp. (D90905), Mycoplasma pneumoniae
(U34795, putative 28-kDa protein), Bacillus sp. (M84963, ORF
5 -adjacent to endo-1,4- -glucanase gene), Methanococcus
jannaschii (U67608), and Caenorhabditis elegans
(Q09524) are aligned with tRNA: 38/39/40 synthase from E. coli (TRUA_ECOLI, P07649) and Saccharomyces
cerevisiae (Deg1, P31115). Higher eukaryotes are presented by the
partial nucleotide sequence of human (zn81c07.s1) Deg1-like protein.
Yeast pseudouridine synthases Pus1 and Pus2 are presented on the
bottom. The number of amino acid residues between blocks and
from the protein termini are indicated by numbers. The
consensus line shows the domains of amino acids that are
conserved in the majority of sequences. Universally or highly conserved
amino acid residues are shaded. U in the
consensus line indicates a hydrophobic residue. The
invariant aspartic acid residue (D) in block II is indicated by
dot. The accession numbers of each sequence and their
respective kingdom (P for prokaryotes, A for
archaea, E for eukaryotes) are given at the end of each
line. The abbreviated names of organisms corresponds to that
in SwissProt.
|
|
Disruption of Deg1 Gene Results in the Disappearance of
tRNA: 38/39 Enzymatic Activity in the Yeast Cell
Extract--
To test the function of yeast Deg1 protein, we performed
one-step gene disruption of the corresponding gene in yeast. The resulting yeast strain remains viable, but the deg1
mutant grows slower compared with parent wild type strain cells as was
reported previously (21). Furthermore, we observed that the slow growth
phenotype is particularly strong at 37 °C (Fig. 2). This thermosensitive phenotype and
growth defect of the deg1 strain could be fully
complemented by expressing the cloned DEG1 gene or the
fusion proteins ProtA-Deg1p and GFP-Deg1 (Fig. 2 and below).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 2.
Disruption of DEG1 leads to slow
growth and a temperature-sensitive phenotype. Serial dilutions of
wild type strain (RS453), deg1 strain, and
deg1 strain transformed by plasmids encoding
for Deg1p or N-terminally tagged forms were spotted on YPD plates and
incubated for 3 days at the indicated temperatures.
|
|
The cell-free extracts (S100) obtained from DEG1-disrupted
and from the wild type yeast strains (used as a control) were
tested for pseudouridine synthase activity using several
synthetic tRNA transcripts as substrates. Taking advantage of 11 different yeast tRNA transcripts labeled internally by appropriate
-32P-NTPs (see "Experimental Procedures"), 10 potential pseudouridylation sites in tRNA molecules were tested (Table
I).
View this table:
[in this window]
[in a new window]
|
Table I
Pseudouridine formation in various tRNA transcripts incubated with
extracts of wild type and DEG1-disrupted yeast strain
|
|
The results indicate that activities for the formation of
13, 27, 28,
32, 34, 35,
36, and 55 are present in both the wild
type and the mutant yeast extracts. Only the pseudouridine synthase
activity toward of U38 and U39 was lacking in
the extract of the DEG1-disrupted strain, whereas the same
uridine residues were modified quantitatively to pseudouridines when
the extract of the wild type strain was used (Table I and Fig.
3). From these results, one can conclude
that the disruption of the DEG1 gene interferes with the
enzymatic formation of both 38 and 39 in anticodon branch of tRNAs.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Time courses of 38 and
39 formation in the extract of wild type (filled
symbols) and DEG1-disrupted yeast strains (open symbols). Pseudouridine formation was measured using as
substrates the transcript of yeast tRNAAla for
38 formation (squares) and
tRNAHis for 39 formation
(circles).
|
|
38/39 Synthase Activity Resides in the Deg1
Protein--
To show that Deg1p is solely responsible for the
modifications missing in the DEG1-disrupted strain, the
recombinant protein was expressed in E. coli and its
activity tested in vitro. The results show that the activity
of tRNA: 38/39 synthase is readily detected in the
extract of E. coli expressing His6-Deg1 and also upon the fractionation of the induced extract on
Ni2+-nitrilotriacetic acid-agarose. Activity of the
expressed yeast pseudouridine synthase was retained considerably by
metal affinity column, and activity toward 38 in yeast
tRNAAla was detected only in the case of induced E. coli extract. Similar results were obtained using purified by
S-Sepharose FF, hydroxyapatite, and Ni2+-nitrilotriacetic
acid-agarose column recombinant Deg1p (more than 95% purity), which
efficiently catalyzes the pseudouridine formation in the transcripts of
yeast tRNAPhe ( 39) and tRNAAla
( 38) (data not shown).
To confirm the above data obtained with Deg1p expressed in E. coli, we created a ProtA-Deg1p fusion protein by tagging to the N
terminus of Deg1p with the IgG binding domain derived from S. aureus protein A. This fusion protein, which is functional since
it can complement the slow growth phenotype of the disrupted strain
(see Fig. 2), was expressed in deg1 cells, and
total cell extract was passed through an IgG-Sepharose column. The only
protein that bound to the column was ProtA-Deg1p as shown by elution at
low pH (Fig. 4A). The
suspension of IgG-Sepharose beads with bound ProtA-Deg1 has been used
as a source of enzyme and tested under standard conditions using the
transcripts of yeast tRNAAla (for 38
formation) and yeast tRNAPhe mutant (PheY55) (for
39 formation). Two independently prepared suspensions
were fully active in reactions leading to both 38 and
39 formation. This experiment confirms that the activity of yeast tRNA: 38/39 synthase resides solely in Deg1
protein (Fig. 4B).

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 4.
Panel A, affinity purification of
ProA-Deg1p by IgG-Sepharose chromatography. Fractions of the soluble
total cell extracts (S), the column flow-through
(FT), the pH 5 wash (W), and the pH 3.4 eluate
(E) were analyzed by SDS-polyacrylamide gel electrophoresis and Coomassie staining (left panel) or immunoblotting with
antibodies that react with the protein A moiety of the fusion protein
(right panel). Panel B, 39 and
38 formation in mutant yeast tRNAPhe
(PheY55) and yeast tRNAAla using the suspension of
IgG-Sepharose with bound ProtA-Deg1 fusion as the source of enzymatic
activity. Time points at 30 and 60 min are presented for
39 formation by two independent preparations of
ProtA-Deg1 (shown as filled and shaded bars).
Only the 60-min point was measured for 38
formation.
|
|
Specificity of Yeast and E. coli tRNA: 38-40
Synthases Is Different--
We compared the specificity of the yeast
and E. coli enzymes using the transcripts of various yeast
and E. coli tRNAs. Fig. 5
shows the anticodon stem-loop regions of the naturally occurring tRNAs,
the transcripts of which were tested for the formation of
38, 39, and 40. As shown
in Fig. 6A (see also Table
II), the transcript of yeast
tRNAHis (anticodon GUG) is modified efficiently to
pseudouridine at position 39 upon the incubation in yeast or E. coli extract.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Anticodon stem-loops of naturally occurring
yeast and E. coli tRNAs. In this study we used as
substrates the corresponding runoff transcripts, lacking all modified
nucleotides.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 6.
Panel A, time courses of
38, 39, and 40 formation
in the transcripts of yeast tRNAAla (triangles),
yeast tRNAHis (squares), and E. coli
tRNASer (circles) incubated, respectively, with
yeast (open symbols, solid lines) and E. coli extracts (filled symbols, dashed
lines). Panel B, time courses of pseudouridine
39 formation in a wild type and mutants of yeast
tRNAPhe(GAA). Wild type yeast extract was used as the
source of enzyme. Wild type tRNAPhe ( ) and mutants
PheY54 ( ) and PheY55 ( ).
|
|
Interestingly, the transcript of yeast tRNAAla remained
completely unmodified while incubated with heterologous E. coli extract. However, the 38-forming activity was
present in the extract as detected using the transcript of homologous
E. coli tRNALeu (Table II). This clearly
demonstrates the existence of species specificity for 38
formation. The corresponding yeast enzyme is apparently less specific
than the E. coli one, as a low but significant level of
38 formation was detected upon the incubation of
E. coli tRNALeu in heterologous yeast extract.
Therefore, the use of yeast tRNAAla allows the reliable
detection of yeast tRNA: 38 synthase activity even in the
presence of the corresponding enzyme from E. coli. Thus the
enzymatic activity toward 38 as detected in the case of
expressed in E. coli His6-tagged Deg1p (see
above) undoubtedly belongs to the expressed yeast protein and not to
endogenous E. coli truAp.
No activity for U40 modification was detected in the yeast
extract using E. coli tRNASer, naturally bearing
40 (Fig. 6A). Interestingly, U40
in yeast tRNAAsp, when incubated with E. coli
extract, becomes converted to 40, albeit at low rate
compared with the rate of U40 modification in the
transcript of E. coli tRNASer (Table II). These
results provide the evidence that the substrate specificity of yeast
and E. coli tRNA: 38/39/(40) synthases is different.
Deg1p Activity Is Sensitive to tRNA Three-dimensional
Structure--
Yeast tRNAPhe (anticodon GAA) is an
excellent experimental model to study the influence of overall
three-dimensional tRNA structure on the modification reaction. This
tRNA naturally contains 14 modified nucleosides, among them two
pseudouridine residues (at positions 39 and 55). The set of
tRNAPhe mutants with well defined disruptions in tertiary
interactions was also available (26). As shown in Fig. 6B
and Table II, almost 1.7 mol of /mol of tRNAPhe
transcript was formed upon the incubation with the yeast extract.
When the transcript of tRNAPhe mutant (PheY54) bearing the
mutation (C56G) in the T loop was incubated with yeast extracts
formation of 39 could be detected only to a very low
level (Fig. 6B and Table II). This low modification level is
most probably the result of the disruption of tertiary interactions
(G19 ... C56) that stabilize the three-dimensional tRNA
architecture (26). For this reason we tested another mutant of yeast
tRNAPhe (PheY55) bearing a compensatory mutation at
position 19 (G19C) which restores tertiary interactions and
consequently the correct tRNA structure (26). The resulting tRNA
transcript became an excellent substrate for yeast
tRNA: 39 synthase present in the extract (Fig.
6B).
In agreement with the observed sensitivity of 39
formation to correct tRNA folding (see above), the results obtained
with RNA minisubstrate consisting of tRNAPhe anticodon loop
(19-mer) show the complete absence of 39 formation (see
also Ref. 27). Likewise, the same stem-loop minisubstrate but prolonged
by a 19-nucleotide intron (36-mer) also remains unmodified (data not
shown).
In summary, the yeast tRNA: 39 synthase appears to be
extremely sensitive to global tRNA structure and, in contrast, to some other tRNA:pseudouridine synthases (e.g. specific for
32 and 55; Ref. 41), it does not
recognize and modify the uridine residues within stem-loop
minisubstrates.
Intracellular Location of Deg1p--
The subcellular localization
of ProtA-tagged Deg1p in yeast cells was analyzed by indirect
immunofluorescence microscopy using tag-specific antibodies and by
direct fluorescence microscopy using a GFP-tagged version of Deg1p
which could also complement the deg1 strain.
In both cases a specific intranuclear signal could be detected, but the
cytoplasm was also diffusely stained (Fig.
7). These results show that Deg1p resides
in both the nucleus and the cytoplasm.

View larger version (78K):
[in this window]
[in a new window]
|
Fig. 7.
Cellular localization of Deg1.
ProtA-Deg1p was localized by indirect immunofluorescent microscopy. The
same sample was also stained for DNA. GFP-Deg1p was observed in living
cells by direct immunofluorescent microscopy. The same cells are also shown by Nomarski optics.
|
|
Pseudouridine Residues 38 and 39 Are
Absent in tRNA from Deg1 Strain--
The cellular
localization of Deg1p studied by immunofluorescence techniques reveals
the presence of nuclear and cytoplasmic pools of the protein but leaves
open the question about its presence in yeast mitochondria. To answer
this question we performed the analysis of pseudouridine residues
present (or absent) in tRNAs extracted from wild type and
DEG1-disrupted strain. Chemical mapping of pseudouridines
was done on total tRNA fraction by CMCT-reverse transcription
technique, as described previously (35). The synthetic oligonucleotides, complementary to the last 18-20 3 -nucleotides in
tRNA, were used for primer extension analysis using unmodified and
CMCT-treated tRNA. The results of reverse transcription for cytoplasmic
tRNAGly (anticodon GCC) and mitochondrial
tRNAArg (anticodon ACG) extracted from wild type and mutant
strains are presented in Fig. 8,
A and B. The strong reverse transcription stops
corresponding to 38 in cytoplasmic tRNAGly
and 39 in mitochondrial tRNAArg are totally
absent in the mutant DEG1-disrupted strain (indicated by
arrows). The formation of other pseudouridines naturally
present in these two tRNAs ( 32 and 55 in
cytoplasmic and mitochondrial tRNA respectively) is not affected by
DEG1 gene disruption. These results confirm the absolute
requirement of Deg1 protein for modification of the pool of cytoplasmic
tRNAs and reveal that the product of the same gene DEG1
participates also in pseudouridine formation in mitochondrial tRNAs.

View larger version (108K):
[in this window]
[in a new window]
|
Fig. 8.
Chemical mapping of pseudouridine residues in
cytoplasmic tRNAGly (panel A) and mitochondrial
tRNAArg (panel B) from wild type and
DEG1-disrupted yeast strains. Autoradiographies of
reverse transcription products in 15% polyacrylamide and 8 M urea gels are shown. The strong stops (shown by
arrows) in reverse transcription of tRNA correspond to
pseudouridine residues. The corresponding tRNA sequencing is shown on
the left of each gel. Control tRNA samples and samples of
tRNA treated by CMCT followed by sodium bicarbonate hydrolysis are
presented side by side.
|
|
Deg1p Is Not Linked Genetically to Pus1p or Los1p--
We have
shown previously that Pus1p interacts genetically with the nuclear
pore-associated proteins Nsp1p and Los1p (9), suggesting that tRNA
modification may be linked to tRNA nuclear export. To test this
possibility for Deg1p, we combined the deg1 disruption with
the los1 or pus1 disruption by mating the
corresponding strains and performing tetrad analysis. The
double-disrupted haploid strains
los1 /deg1 and
pus1 /deg1 were viable
and did not exhibit any further growth defect than the single-disrupted
deg1 strain (data not shown). Therefore, the
functional interaction with the nuclear pore complex appears to be
specific for Pus1p and does not occur in the case of Deg1p, suggesting
that modification only at particular sites is important for the tRNA
transport process. Furthermore, the viability of the
pus1 /deg1 strain
shows that yeast cells can tolerate the absence of modification in
positions 27, 34, 36, 38, and 39. Thus, despite the different specificity of Pus1p and Pus3p there is no obvious synergism between them.
 |
DISCUSSION |
Yeast Protein Deg1 Is tRNA: 38/39
Synthase--
Direct evidence that the yeast Deg1 protein is a
tRNA:pseudouridine synthase comes from two types of experiments: by
detecting the corresponding enzymatic activity in S100 extracts of a
transformed E. coli strain harboring the yeast
DEG1 gene and by measuring the enzymatic activity of a
ProtA-Deg1 fusion protein purified from a deg1
yeast strain. In both cases, the protein catalyzes in vitro
formation of pseudouridines at position 38 or 39 of several tRNA
transcripts. Additional evidence came also from identification of the
lacking pseudouridines at position 38 or 39 in cytoplasmic
tRNAGly and in mitochondrial tRNAArg present in
DEG1-disrupted yeast strain. As predicted previously (21),
Deg1p is indeed the yeast homolog of E. coli tRNA:
synthase I (PSU-I, also called truA, initially discovered as
hisT gene product). Therefore, after Pus1 and Pus2 (9), this
is the third tRNA: synthase (PseudoUridine
Synthase, Pus3) so far characterized in yeast.
Yeast Pus3 and E. coli truA Display Different Substrate
Specificity--
Testing several tRNA substrates allowed us to reveal
subtle differences in substrate specificity between yeast Deg1p and
E. coli truAp. Indeed, although both enzymes display rather
good cross-reactivity toward uridine 39 in two different tRNA
transcripts (tRNAPhe and tRNAHis), the
situation for 38 and 40 formation was
different. E. coli truA modified U40 fairly well
in both E. coli tRNASer and yeast
tRNAAsp, whereas the yeast Deg1p did not modify
U40 at all in the same tRNA transcripts. This observation
fits well with the fact that U40 in naturally occurring
yeast tRNAAsp is not modified into , but in E. coli all U40-containing tRNAs bear 40
(42). This absence of 40 is valid only for tRNAs from fungi and does not apply for tRNAs from higher eukaryotes, where few
cases of 40-containing tRNAs were found (42). However, the above observation for U/ 40 relationship in yeast
tRNAs is valid for both yeast cytoplasmic and the mitochondrial tRNAs, as in cytoplasm, several naturally occurring yeast mitochondrial tRNAs
contain 38 or 39 but not
40. This is consistent with the fact that the same gene
product modifies all tRNA substrates in the different cellular
compartments in yeast (nucleus, cytoplasm, and mitochondria; see
below).
In transcripts of yeast tRNAAla and E. coli
tRNALeu, U38 was modified with different
efficiency by yeast or E. coli enzymes. Yeast enzyme
catalyzes the 38 formation in both transcripts, whereas the E. coli homolog is exclusively specific toward E. coli tRNA. Indeed, inspecting the tRNA sequence data bank (42) we
notice that all four yeast U38-containing tRNAs are fully
modified to 38, but in E. coli only five out
of eight U38 are converted to 38. It is
interesting to note that all five 38-containing E. coli tRNAs bear G36 in the anticodon, whereas the
other unmodified U38-containing E. coli tRNA
have a C36. Therefore the presence of a G36 (or
C36) could act as a positive (or negative) determinant for
E. coli truAp.
Because all U38- or U39-containing cytoplasmic
tRNAs in yeast (22 out of 34 sequenced so far (42)), despite very
different nucleotide sequences, are modified to
38/ 39, this suggests that there might be
no other essential nucleotides (identity elements) needed for the
recognition by Deg1 enzyme.
In contrast, the overall three-dimensional structure of tRNA molecule
seems to be important for tRNA recognition. Indeed, the
tRNAPhe mutant with disrupted interaction between T and
D loops was a rather weak substrate compared with the wild type
tRNAPhe. The double mutant restoring the three-dimensional
pairing became again a good substrate for the yeast Deg1p. Moreover,
none of the fragmented or minimalist tRNAPhe served as a
substrate for the yeast Deg1p. Thus, the enzyme catalyzing the
formation of 38 or 39 in yeast tRNAs
clearly belongs to the group II of tRNA modification enzymes, which are
sensitive to three-dimensional perturbation of the tRNA architecture
(41).
A Single Nuclear Gene DEG1 Provides the Enzyme for Three Cellular
Compartments--
Immunochemical studies demonstrate that Deg1 protein
is mostly located in the nucleus, but a significant part of it is also found in the yeast cytoplasm. Moreover, the analysis of the
pseudouridine tRNA modification pattern in the
DEG1-disrupted strain demonstrates clearly that a single
gene DEG1 is responsible for the enzymatic formation of
38/39 in both cytoplasmic and mitochondrial tRNAs.
A similar situation has been already ascribed to a few other tRNA
modification enzymes in yeast. The yeast tRNA modification enzyme
Mod5p, which catalyzes the formation of isopentenyladenosine in the
anticodon loop of several yeast tRNAs, apparently behaves similarly,
and its cellular location resembles the one observed for Deg1p (43,
44). In both cases, the enzymes were located mainly in the nucleus, but
a significant amount was also detected in the cytoplasm. In contrast,
yeast Trm1p, the enzyme catalyzing the formation of
N2,N2-dimethylguanosine
26 in several yeast tRNAs, was shown to be located at the nuclear
internal periphery, and no significant signal was detected in the
cytoplasm (45). The reason why Mod5p and Deg1p are present in
both the cytoplasm and the nucleus but Trm1p as well as Pus1p (9) are
almost exclusively nuclear is probably related to the temporal events
in which these enzymes have to function during the complex tRNA
maturation process.
Deg1p Belongs to a truA-like Family That Is Distinct from All Other
RNA: Synthases Sequenced So Far--
Comparison of the amino acid
sequences of 12 truA-like proteins identified so far from
different organisms reveals the presence of highly conserved residues
(shown in gray in Fig. 1) within six blocks that are common
to all proteins of the family. Interestingly, almost the
same signature is present in Pus1p and Pus2p but is not found in any
other protein of the whole protein data bank (SwissProt and GenBank).
Only the sequence GRTDXGVHXG (block II in Fig.
1), bearing a conserved aspartic acid residue (indicated by a
dot in Fig. 1), is similar to amino acid sequence
GXRDXXXG (also referred as block II
by Koonin (40)) present in all other RNA:pseudouridine synthases. As
already proposed by Koonin, this universally conserved aspartic acid
residue may be implicated in the enzymatic catalysis. Recent
cross-linking studies and site-directed mutagenesis performed on
E. coli tRNA pseudouridine synthase I (prokaryotic homolog
of Pus3) clearly demonstrate that Asp-60 residue is essential for
enzymatic activity (46). Successful crystallization and resolution of
the structure of E. coli tRNA pseudouridine synthase I have
also been reported (47), which should shed light on the catalytic
mechanism of the uridine isomerization.
The fact that Pus1p and Deg1p (Pus3p) belong to the same family
(truA-like family) may be related to the RNA recognition mode. Indeed,
both Pus1p and Deg1p are multisite-specific enzymes that catalyze the
formation of pseudouridines in 1, 2, or 3 positions within a given
region of tRNA (positions 27 and 28 as well as positions 34, 35, and 36 for Pus1p (9) or positions 38 and 39 for Deg1p; this paper).
In agreement with the recent observation that none of the cysteine
residues present in E. coli truAp is required for its
enzymatic activity (48), no conserved cysteine is detected in the
alignment of the various truA-like proteins.
Disruption of the DEG1 Gene Influences Yeast Cell Growth--
In
yeast, gene DEG1 was discovered incidentally by
transcriptional analysis of the centromere region of yeast chromosome
VI. This gene is located very close to the centromere and is expressed at only a low level. Its disruption, although not lethal, causes a
pronounced slow growth phenotype (DEpressed
Growth) (21). In this work, we show that this slow growth
phenotype, which is much more pronounced at 37 °C, is entirely the
result of the absence of Deg1 protein as it can be complemented by the
corresponding gene or by clones expressing N-terminally tagged
proteins. The absence of the Deg1p correlates with the absence of at positions 38 and 39 of tRNA.
The strong relationship between the reduced growth rate of E. coli or S. typhimurium and the absence of
pseudouridines 38/39/40 in anticodon stem-loop of several tRNAs was
observed more than 2 decades ago (49). This reduced growth rate was
correlated with the derepression of several amino acid operons by an
attenuation type of mechanism as demonstrated in the case of the
his operon (50). Because different kinds of nonsense,
missense, or frameshift tRNA suppressors were also affected by the
hisT mutation (reviewed in Ref. 51), it is now
evident that major function of the hisT gene product
in prokaryotes is related to protein synthesis on the ribosome. Thus,
pseudouridylation of the anticodon loop and its proximal stem in
prokaryotic tRNAs has a central role in regulation of cellular
metabolism.
Yeast cells lacking pseudouridine 38/39 synthase activity
(DEG1-disrupted strain) display slow growth phenotype,
similar to the one observed for E. coli and the
Salmonella hisT mutant. Therefore, as in prokaryotes, the
pseudouridines in tRNA anticodon stem-loop are also important for the
modulation of the translation process in yeast. Attenuation type of
gene regulation cannot occur in eukaryotic cells because of the
different compartmentalization of the transcription and the translation
machinery. However, the absence of 38/39 in yeast tRNA
may affect the rate of mRNA decoding on the ribosome.
An alternative explanation could be that deletion of DEG1
gene affects primarily the mitochondrial translation process by prokaryotic-type attenuation mechanism giving rise the phenotype similar to the one observed in the case of mitochondrial disorders such
as mioclonic epilepsy and ragged red fibers syndrome (MERRF) or
mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS) (52).
 |
ACKNOWLEDGEMENTS |
The plasmids containing various tRNA genes
were kindly provided by Drs. O.Uhlenbeck (Boulder, CO-USA),
R.Giegé and F.Fasiolo (IBMC, Strasbourg, France), J.Bell (Univ.
of Alberta, Canada) and Z.Szweykowska-Kulinska (Univ. of Poznan,
Poland). The plasmid carrying the PNop1-GFP cassette was
kindly provided by K. Hellmuth. We thank Dr. J-P. Waller (CNRS,
Gif-sur-Yvette) for critical reading of the manuscript and useful
comments.
 |
FOOTNOTES |
*
This work was supported in part by research grants from CNRS
and Actions de la Recherche sur le Cancer (to H. G.) and by Research Grant Hu363/6-2 from the Deutsche Forschungsgemeinschaft (to
E. C. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Supported by the Medical Research Council of Canada Operating
Grant MRC-MT-1226 awarded to Dr. B. Lane, University of Toronto, Canada. Correspondence should be addressed to Y. Motorin, Laboratoire d'Enzymologie et Biochimie Structurales, Avenue de la Terrasse, Bat.
34, CNRS, Gif-sur-Yvette, France. Tel.: 33-1-6982-3498; Fax: 33-1-6982-3129; E-mail: Yuri.Motorin{at}lebs.cnrs-gif.fr.
1
The abbreviations used are: , pseudouridine
(5-( -D-ribofuranosyl)uracil; CMCT,
1-cyclohexyl-3-(2-morpholinoethyl)-carbodiimide metho-p-toluenesulfonate; PCR, polymerase chain reaction;
ORF, open reading frame; GFP, green fluorescent protein; ProtA,
S. aureus protein A; Bicine,
N,N-bis(2-hydroxyethyl)glycine.
2
K. Hellmuth and E. C. Hurt, unpublished
data.
 |
REFERENCES |
-
Limbach, P. A.,
Crain, P. F.,
and McCloskey, J. A.
(1994)
Nucleic Acids Res.
22,
2183-2196[Abstract/Free Full Text]
-
Grosjean, H.,
Sprinzl, M.,
and Steinberg, S.
(1995)
Biochimie (Paris)
77,
139-141[Medline]
[Order article via Infotrieve]
-
Maden, B. E. H.
(1990)
Prog. Nucleic Acid Res.
39,
241-303[Medline]
[Order article via Infotrieve]
-
Ofengand, J.,
and Bakin, A.
(1997)
J. Mol. Biol.
266,
246-268[CrossRef][Medline]
[Order article via Infotrieve]
-
Patton, J. R.
(1994)
Biochimie (Paris)
76,
1129-1132[Medline]
[Order article via Infotrieve]
-
Gu, J.,
Patton, J. R.,
Shimba, S.,
and Reddy, R.
(1996)
RNA
2,
909-918[Abstract]
-
Wise, J. A.,
Tollervey, D.,
Maloney, D.,
Swerdlow, H.,
Dunn, E. J.,
Guthrie, C.
(1983)
Cell
35,
743-751[CrossRef][Medline]
[Order article via Infotrieve]
-
Samuelsson, T.,
and Olsson, M.
(1990)
J. Biol. Chem.
265,
8782-8787[Abstract/Free Full Text]
-
Simos, G.,
Tekotte, H.,
Grosjean, H.,
Segref, A.,
Sharma, K.,
Tollervey, D.,
and Hurt, E. C.
(1996)
EMBO J.
15,
2270-2284[Medline]
[Order article via Infotrieve]
-
Ni, J.,
Tien, A. L.,
and Fournier, M. J.
(1997)
Cell
89,
565-573[CrossRef][Medline]
[Order article via Infotrieve]
-
Ganot, P.,
Bortolin, M. L.,
and Kiss, T.
(1997)
Cell
89,
799-809[CrossRef][Medline]
[Order article via Infotrieve]
-
Smith, C. M.,
and Steitz, J. A.
(1997)
Cell
89,
669-672[CrossRef][Medline]
[Order article via Infotrieve]
-
Arena, F.,
Ciliberto, G.,
Ciampi, S.,
and Cortese, R.
(1978)
Nucleic Acids Res.
5,
4523-4536[Abstract/Free Full Text]
-
Kammen, H. O.,
Marvel, C. C.,
Hardy, L.,
and Penhoet, E. E.
(1988)
J. Biol. Chem.
263,
2255-2263[Abstract/Free Full Text]
-
Arps, P. J.,
Marvel, C. C.,
Rubin, B. C.,
Tolan, D. A.,
Penhoet, E. E.,
Winkler, M. E.
(1985)
Nucleic Acids Res.
13,
5297-5315[Abstract/Free Full Text]
-
Green, C. J.,
Kammen, H. O.,
and Penhoet, E. E.
(1982)
J. Biol. Chem.
257,
3045-3052[Abstract/Free Full Text]
-
Nurse, K.,
Wrzesinski, J.,
Bakin, A.,
Lane, B. G.,
Ofengand, J.
(1995)
RNA
1,
102-112[Abstract]
-
Wrzesinski, J.,
Nurse, K.,
Bakin, A.,
Lane, B. G.,
Ofengand, J.
(1995)
RNA
1,
437-448[Abstract]
-
Wrzesinski, J.,
Bakin, A.,
Nurse, K.,
Lane, B. G.,
Ofengand, J.
(1995)
Biochemistry
34,
8904-8913[CrossRef][Medline]
[Order article via Infotrieve]
-
Grosjean, H.,
Szweykowska-Kulinska, Z.,
Motorin, Y.,
Fasiolo, F.,
and Simos, G.
(1997)
Biochimie (Paris)
79,
293-302[Medline]
[Order article via Infotrieve]
-
Carbone, M. L.,
Solinas, M.,
Sora, S.,
and Panzeri, L.
(1991)
Curr. Genet.
19,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
-
Perret, V.,
Garcia, A.,
Puglisi, J.,
Grosjean, H.,
Ebel, J.-P.,
Florentz, C.,
and Giegé, R.
(1990)
Biochimie (Paris)
72,
735-744[Medline]
[Order article via Infotrieve]
-
Szweykowska-Kulinska, Z.,
Senger, B.,
Keith, G.,
Fasiolo, F.,
and Grosjean, H.
(1994)
EMBO J.
13,
4636-4644[Medline]
[Order article via Infotrieve]
-
Swerdlow, H.,
and Guthrie, C.
(1984)
J. Biol. Chem.
259,
5197-5207[Abstract/Free Full Text]
-
Motorin, Y. A.,
Bec, G.,
Tewari, R.,
and Grosjean, H.
(1997)
RNA
3,
721-733[Abstract]
-
Sampson, J.,
DiRenzo, A. B.,
Behlen, L. S.,
Uhlenbeck, O. C.
(1990)
Biochemistry
29,
2523-2532[CrossRef][Medline]
[Order article via Infotrieve]
-
Jiang, H.-Q.,
Motorin, Y. A.,
Jin, Y.-X.,
and Grosjean, H.
(1997)
Nucleic Acids Res.
25,
2694-2701[Abstract/Free Full Text]
-
Auxilien, S.,
Crain, P. F.,
Trewyn, R. W.,
Grosjean, H.
(1996)
J. Mol. Biol.
262,
437-458[CrossRef][Medline]
[Order article via Infotrieve]
-
Wimmer, C.,
Doye, V.,
Grandi, P.,
Nehrbass, U.,
and Hurt, E.
(1992)
EMBO J.
11,
5051-5061[Medline]
[Order article via Infotrieve]
-
Sherman, F.
(1990)
Methods Enzymol.
194,
3-20
-
Rothstein, R.
(1983)
Methods Enzymol.
101,
202-211[Medline]
[Order article via Infotrieve]
-
Simos, G.,
Segref, A.,
Fasiolo, F.,
Hellmuth, K.,
Shevchenko, A.,
Mann, M.,
and Hurt, E. C.
(1996)
EMBO J.
15,
5437-5448[Medline]
[Order article via Infotrieve]
-
Kahana, J.,
and Silver, P.
(1996)
Curr. Protocols Mol. Biol.
9,
722-728
-
Shibasaki, F.,
Price, E. R.,
Milan, D.,
and McKeon, F.
(1996)
Nature
382,
370-373[CrossRef][Medline]
[Order article via Infotrieve]
-
Bakin, A.,
and Ofengand, J.
(1993)
Biochemistry
32,
9754-9762[CrossRef][Medline]
[Order article via Infotrieve]
-
Bakin, A.,
and Ofengand, J.
(1995)
Nucleic Acids Res.
23,
3290-3294[Abstract/Free Full Text]
-
Sherman, F.,
Fink, G. R.,
and Hicks, J. B. N.
(1986)
Methods in Yeast Genetics: A Laboratory Course Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
-
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
-
Koonin, E. V.
(1996)
Nucleic Acids Res.
24,
2411-2415[Abstract/Free Full Text]
-
Grosjean, H.,
Edqvist, J.,
Sträby, K. B.,
Giegé, R.
(1996)
J. Mol. Biol.
255,
67-85[CrossRef][Medline]
[Order article via Infotrieve]
-
Sprinzl, M.,
Steegborn, C.,
Hubel, F.,
and Steinberg, S.
(1996)
Nucleic Acids Res.
24,
68-72[Free Full Text]
-
Boguta, M.,
Hunter, L. A.,
Shen, W. C.,
Gillman, E. C.,
Martin, N. C.,
Hopper, A. K.
(1994)
Mol. Cell. Biol.
14,
2298-2306[Abstract/Free Full Text]
-
Martin, N. C.,
and Hopper, A. K.
(1994)
Biochimie (Paris)
76,
1161-1167[Medline]
[Order article via Infotrieve]
-
Rose, A. M.,
Belford, H. G.,
Shen, W. C.,
Greer, C. L.,
Hopper, A. K.,
Martin, N. C.
(1995)
Biochimie (Paris)
77,
45-53[Medline]
[Order article via Infotrieve]
-
Huang, L.,
Pookanjanatavip, M.,
and Santi, D. V.
(1997)
FASEB J.
11,
1320 (abstr.)
-
Foster, P. G.,
Huang, L.,
Santi, D. V.,
Stroud, R. M.
(1997)
FASEB J.
11,
862 (abstr.)
-
Zhao, X.,
and Horne, D. A.
(1997)
J. Biol. Chem.
272,
1950-1955[Abstract/Free Full Text]
-
Singer, C. E.,
Smith, G. R.,
Cortese, R.,
and Ames, B. N.
(1972)
Nature New Biol.
238,
72-74[Medline]
[Order article via Infotrieve]
-
Barnes, W. M.
(1978)
Proc. Natl. Acad. Sci. U. S. A.
75,
4281-4285[Abstract/Free Full Text]
-
Björk, G. R.
(1995)
in
tRNA: Structure, Biosynthesis, and Function (Söll, D., and RajBhandary, U., eds), pp. 165-206, American Society for Microbiology Press, Washington, D. C.
-
Wallace, D. C.
(1993)
Trends Genet.
9,
128-133[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Muller, A. Urban, A. Hecker, F. Leclerc, C. Branlant, and Y. Motorin
Deficiency of the tRNATyr:{Psi}35-synthase aPus7 in Archaea of the Sulfolobales order might be rescued by the H/ACA sRNA-guided machinery
Nucleic Acids Res.,
March 1, 2009;
37(4):
1308 - 1322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Z. Anderson, J. Brewer, U. Singh, and J. C. Boothroyd
A Pseudouridine Synthase Homologue Is Critical to Cellular Differentiation in Toxoplasma gondii
Eukaryot. Cell,
March 1, 2009;
8(3):
398 - 409.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Kotelawala, E. J. Grayhack, and E. M. Phizicky
Identification of yeast tRNA Um44 2'-O-methyltransferase (Trm44) and demonstration of a Trm44 role in sustaining levels of specific tRNASer species
RNA,
January 1, 2008;
14(1):
158 - 169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Behm-Ansmant, C. Branlant, and Y. Motorin
The Saccharomyces cerevisiae Pus2 protein encoded by YGL063w ORF is a mitochondrial tRNA:{Psi}27/28-synthase
RNA,
October 1, 2007;
13(10):
1641 - 1647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhao, J. R. Patton, S. K. Ghosh, N. Fischel-Ghodsian, L. Shen, and R. A. Spanjaard
Pus3p- and Pus1p-Dependent Pseudouridylation of Steroid Receptor RNA Activator Controls a Functional Switch that Regulates Nuclear Receptor Signaling
Mol. Endocrinol.,
March 1, 2007;
21(3):
686 - 699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Fernandez-Vizarra, A. Berardinelli, L. Valente, V. Tiranti, and M. Zeviani
Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA)
J. Med. Genet.,
March 1, 2007;
44(3):
173 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takeda, T. Toyooka, Y. Ikeuchi, S.-i. Yokobori, K. Okadome, F. Takano, T. Oshima, T. Suzuki, Y. Endo, and H. Hori
The substrate specificity of tRNA (m1G37) methyltransferase (TrmD) from Aquifex aeolicus
Genes Cells,
December 1, 2006;
11(12):
1353 - 1365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. COPELA, G. CHAKSHUSMATHI, R. L. SHERRER, and S. L. WOLIN
The La protein functions redundantly with tRNA modification enzymes to ensure tRNA structural stability.
RNA,
April 1, 2006;
12(4):
644 - 654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cabello-Villegas and E. P. Nikonowicz
Solution structure of {psi}32-modified anticodon stem-loop of Escherichia coli tRNAPhe
Nucleic Acids Res.,
December 23, 2005;
33(22):
6961 - 6971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Patton, Y. Bykhovskaya, E. Mengesha, C. Bertolotto, and N. Fischel-Ghodsian
Mitochondrial Myopathy and Sideroblastic Anemia (MLASA): MISSENSE MUTATION IN THE PSEUDOURIDINE SYNTHASE 1 (PUS1) GENE IS ASSOCIATED WITH THE LOSS OF tRNA PSEUDOURIDYLATION
J. Biol. Chem.,
May 20, 2005;
280(20):
19823 - 19828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. ALEXANDROV, E. J. GRAYHACK, and E. M. PHIZICKY
tRNA m7G methyltransferase Trm8p/Trm82p: Evidence linking activity to a growth phenotype and implicating Trm82p in maintaining levels of active Trm8p
RNA,
May 1, 2005;
11(5):
821 - 830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Behm-Ansmant, H. Grosjean, S. Massenet, Y. Motorin, and C. Branlant
Pseudouridylation at Position 32 of Mitochondrial and Cytoplasmic tRNAs Requires Two Distinct Enzymes in Saccharomyces cerevisiae
J. Biol. Chem.,
December 17, 2004;
279(51):
52998 - 53006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Okamoto, K. Watanabe, Y. Ikeuchi, T. Suzuki, Y. Endo, and H. Hori
Substrate tRNA Recognition Mechanism of tRNA (m7G46) Methyltransferase from Aquifex aeolicus
J. Biol. Chem.,
November 19, 2004;
279(47):
49151 - 49159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Xing, S. L. Hiley, T. R. Hughes, and E. M. Phizicky
The Specificities of Four Yeast Dihydrouridine Synthases for Cytoplasmic tRNAs
J. Biol. Chem.,
April 23, 2004;
279(17):
17850 - 17860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Roovers, J. Wouters, J. M. Bujnicki, C. Tricot, V. Stalon, H. Grosjean, and L. Droogmans
A primordial RNA modification enzyme: the case of tRNA (m1A) methyltransferase
Nucleic Acids Res.,
January 22, 2004;
32(2):
465 - 476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Gu, J. E. Jackman, A. J. Lohan, M. W. Gray, and E. M. Phizicky
tRNAHis maturation: An essential yeast protein catalyzes addition of a guanine nucleotide to the 5' end of tRNAHis
Genes & Dev.,
December 1, 2003;
17(23):
2889 - 2901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. BEHM-ANSMANT, A. URBAN, X. MA, Y.-T. YU, Y. MOTORIN, and C. BRANLANT
The Saccharomyces cerevisiae U2 snRNA:pseudouridine-synthase Pus7p is a novel multisite-multisubstrate RNA:{Psi}-synthase also acting on tRNAs
RNA,
November 1, 2003;
9(11):
1371 - 1382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hori, S. Kubota, K. Watanabe, J.-M. Kim, T. Ogasawara, T. Sawasaki, and Y. Endo
Aquifex aeolicus tRNA (Gm18) Methyltransferase Has Unique Substrate Specificity: tRNA RECOGNITION MECHANISM OF THE ENZYME
J. Biol. Chem.,
June 27, 2003;
278(27):
25081 - 25090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. KAYA and J. OFENGAND
A novel unanticipated type of pseudouridine synthase with homologs in bacteria, archaea, and eukarya
RNA,
June 1, 2003;
9(6):
711 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. JACKMAN, R. K. MONTANGE, H. S. MALIK, and E. M. PHIZICKY
Identification of the yeast gene encoding the tRNA m1G methyltransferase responsible for modification at position 9
RNA,
May 1, 2003;
9(5):
574 - 585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Hopper and E. M. Phizicky
tRNA transfers to the limelight
Genes & Dev.,
January 15, 2003;
17(2):
162 - 180.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mengel-Jorgensen and F. Kirpekar
Detection of pseudouridine and other modifications in tRNA by cyanoethylation and MALDI mass spectrometry
Nucleic Acids Res.,
December 1, 2002;
30(23):
e135 - e135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lecointe, O. Namy, I. Hatin, G. Simos, J.-P. Rousset, and H. Grosjean
Lack of Pseudouridine 38/39 in the Anticodon Arm of Yeast Cytoplasmic tRNA Decreases in Vivo Recoding Efficiency
J. Biol. Chem.,
August 16, 2002;
277(34):
30445 - 30453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gro{beta}hans, F. Lecointe, H. Grosjean, E. Hurt, and G. Simos
Pus1p-dependent tRNA Pseudouridinylation Becomes Essential When tRNA Biogenesis Is Compromised in Yeast
J. Biol. Chem.,
November 30, 2001;
276(49):
46333 - 46339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hellmuth, H. Grosjean, Y. Motorin, K. Deinert, E. Hurt, and G. Simos
Cloning and characterization of the Schizosaccharomyces pombe tRNA:pseudouridine synthase Pus1p
Nucleic Acids Res.,
December 1, 2000;
28(23):
4604 - 4610.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu and K. B. Straby
The human tRNA(m22G26)dimethyltransferase: functional expression and characterization of a cloned hTRM1 gene
Nucleic Acids Res.,
September 15, 2000;
28(18):
3445 - 3451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ansmant, S. Massenet, H. Grosjean, Y. Motorin, and C. Branlant
Identification of the Saccharomyces cerevisiae RNA:pseudouridine synthase responsible for formation of {Psi}2819 in 21S mitochondrial ribosomal RNA
Nucleic Acids Res.,
May 1, 2000;
28(9):
1941 - 1946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Ganot, B. E. Jady, M.-L. Bortolin, X. Darzacq, and T. Kiss
Nucleolar Factors Direct the 2'-O-Ribose Methylation and Pseudouridylation of U6 Spliceosomal RNA
Mol. Cell. Biol.,
October 1, 1999;
19(10):
6906 - 6917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Ramamurthy, S. L. Swann, J. L. Paulson, C. J. Spedaliere, and E. G. Mueller
Critical Aspartic Acid Residues in Pseudouridine Synthases
J. Biol. Chem.,
August 6, 1999;
274(32):
22225 - 22230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Massenet, Y. Motorin, D. L. J. Lafontaine, E. C. Hurt, H. Grosjean, and C. Branlant
Pseudouridine Mapping in the Saccharomyces cerevisiae Spliceosomal U Small Nuclear RNAs (snRNAs) Reveals that Pseudouridine Synthase Pus1p Exhibits a Dual Substrate Specificity for U2 snRNA and tRNA
Mol. Cell. Biol.,
March 1, 1999;
19(3):
2142 - 2154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Conrad, D. Sun, N. Englund, and J. Ofengand
The rluC Gene of Escherichia coli Codes for a Pseudouridine Synthase That Is Solely Responsible for Synthesis of Pseudouridine at Positions 955, 2504, and 2580 in 23 S Ribosomal RNA
J. Biol. Chem.,
July 17, 1998;
273(29):
18562 - 18566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ansmant, Y. Motorin, S. Massenet, H. Grosjean, and C. Branlant
Identification and Characterization of the tRNA:Psi 31-Synthase (Pus6p) of Saccharomyces cerevisiae
J. Biol. Chem.,
September 7, 2001;
276(37):
34934 - 34940.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|